SecBot SecBot
8-K ·Filed Oct 16, 2026

MDCX

Medicus Pharma Ltd.
NEUTRAL
Impact 3/10
Horizonimmediate Processed11d ago SEC0001062993-26-005382
8-K context-dependent: Items 3.03
Actionable Insight • Neutral

Reverse split is a mechanical adjustment with no fundamental change to the business. Monitor for potential Nasdaq compliance benefits or subsequent capital markets activity, but no immediate trading catalyst.

DirectionNeutral
Confidencehigh
Horizonimmediate
Latest settled — T+5d
MDCX ▼ -5.46% at T+5d
NEUTRAL call -5.46% · α vs SPY -5.32% · entry $2.66 → $2.51
Next anchor: T+20d in 17d
Entry = T+0 close
Oct 16, 2026
via day close
T+1d
+2.45%
call +2.45% · α +2.11%
$2.72
settled 8d ago
T+5d
-5.46%
call -5.46% · α -5.32%
$2.51
settled 4d ago
T+20d
Pending
in 17d
T+60d
Pending
in 3mo

Price Chart

Loading chart...

Executive Summary

Medicus Pharma Ltd. filed an 8-K reporting a 1-for-50 reverse stock split (share consolidation) effective October 12, 2026. The consolidation was approved by shareholders on June 3, 2026, and the board set the ratio on September 24, 2026. No fractional shares were issued; cash was paid in lieu. The filing is a routine capital structure adjustment with no new financial data or operational changes.

Key Facts

  • 1-for-50 share consolidation effective October 12, 2026
  • Shareholder approval obtained June 3, 2026; board set ratio September 24, 2026
  • No fractional shares issued; cash paid in lieu of fractional shares
  • Proportionate adjustments made to equity awards, convertible securities, and warrants
  • Ownership percentages did not meaningfully change

Financial Impact

No financial impact from the consolidation itself; share count reduced by 98%, share price expected to adjust proportionally

share countshare price

Risk Factors

  • Reverse splits often signal prior stock price distress and can be viewed negatively by the market
  • Reduced liquidity from lower share count may increase volatility

Investment Themes

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001062993-26-005382
Document: 0001062993-26-005382-index-headers.html0001062993-26-005382
Document: 0001062993-26-005382-index.html0001062993-26-005382
Document: 0001062993-26-005382.txt0001062993-26-005382
16 reports for MDCX
Performance horizon
50% Hit rate @ T+1 5 of 10 directional calls Went positive at some point 7 of 10 best @ T+20▲ +43.36%Sep 11, 2026
Filters
Rows
Reports for MDCX — sortable, filterable
TypeNow
Oct 23, 2026
4d ago
8-K
NEUTRAL ★ 5/10
$2.51 $2.45▼ −2.39%▼ −2.95%$2.45 (−2.39%)
Oct 16, 2026
11d ago
8-K
NEUTRAL ★ 3/10
$2.66 $2.72▲ +2.45%▲ +2.11%$2.45 (−7.72%)
Oct 16, 2026
11d ago
SC 13G/A
NEUTRAL ★ 3/10
$2.66 $2.72▲ +2.45%▲ +2.11%$2.45 (−7.72%)
Oct 7, 2026
20d ago
8-K
NEUTRAL ★ 4/10
$0.1019 $0.0921▼ −9.62%▼ −10.22%$2.45 (+2304.32%)
Sep 14, 2026
6w ago
8-K
NEUTRAL ★ 4/10
$0.1593 $0.1521▼ −4.52%▼ −4.06%$2.45 (+1437.98%)
Sep 11, 2026
6w ago
8-K
BEARISH ★ 6/10
$0.1626 $0.1593▲ +2.03%▲ +1.58%$2.45 (−1406.77%)
Sep 10, 2026
6w ago
Press Release
BULLISH ★ 6/10
$0.1614 $0.1626▲ +0.74%▼ −0.11%$2.45 (+1417.97%)
Sep 3, 2026
7w ago
8-K
BULLISH ★ 7/10
$0.1705 $0.1720▲ +0.88%▲ +1.27%$2.45 (+1336.95%)
Jul 16, 2026
14w ago
Press Release
BULLISH ★ 5/10
$0.4060 $0.3758▼ −7.44%▼ −6.45%$2.45 (+503.45%)
May 14, 2026
23w ago
Press Release
BEARISH ★ 6/10
$0.3010 $0.2910▲ +3.32%▲ +3.26%$2.45 (−713.95%)
Showing 10 of 16

US Market Status

Market Closed — Opens Wed (15h 41m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Oct 16, 2026